3 Hits in 3.4 sec

Recent omics-based computational methods for COVID-19 drug discovery and repurposing

Hilal Tayara, Ibrahim Abdelbaky, Kil To Chong
2021 Briefings in Bioinformatics  
Many efforts in recent months utilized Artificial Intelligence (AI) techniques in the context of fighting the spread of COVID-19.  ...  Therefore, researchers are in a race against the time to produce potential treatments to cure or reduce the increasing infections of COVID-19.  ... navirus COVID-KOP Integrates Reasoning Over Biomedical Objects (ROBOKOP) with biomedical literature in the CORD-19 collection Data source  ... 
doi:10.1093/bib/bbab339 pmid:34423353 fatcat:ks5kgdub45henlols2xkddpgn4

A critical overview of computational approaches employed for COVID-19 drug discovery

Eugene N. Muratov, Rommie Amaro, Carolina H. Andrade, Nathan Brown, Sean Ekins, Denis Fourches, Olexandr Isayev, Dima Kozakov, José L. Medina-Franco, Kenneth M. Merz, Tudor I. Oprea, Vladimir Poroikov (+7 others)
2021 Chemical Society Reviews  
We cover diverse methodologies, computational approaches, and case studies illustrating the ongoing efforts to develop viable drug candidates for treatment of COVID-19.  ...  edges between 100 thousand entities of 13 entity types. 157 ther open source COVID-19 KGs include the extension of ROBOKOP to COVID-KOP by researchers at the University of North Carolina, 158 and KG-COVID  ...  -19 by investigators at Berkeley, California. 159 The ROBOKOP biomedical KG was enriched with information from recent biomedical literature on COVID-19 annotated in the CORD-19 collection.  ... 
doi:10.1039/d0cs01065k pmid:34212944 pmcid:PMC8371861 fatcat:n6dxyyjxifh6hoehd7myapjtwu

Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: lessons from the pandemic and preparing for future health crises

Natesh Singh, Bruno O Villoutreix
2021 Computational and Structural Biotechnology Journal  
But, while the race to find vaccines for COVID-19 has dominated the headlines, other types of therapeutic agents are being developed.  ...  There is an urgent need to identify new therapies that prevent SARS-CoV-2 infection and improve the outcome of COVID-19 patients.  ...  could have appeared to influence the work reported in this paper.  ... 
doi:10.1016/j.csbj.2021.04.059 pmid:33936562 pmcid:PMC8074526 fatcat:brqnldsbkvftlhbre4ax63dcfq